Targeting host E-selectin expression by antisense oligodeoxynucleotides as potential antiendotoxin therapy in vivo

This study sought to determine if antisense oligodeoxynucleotides would inhibit E-selectin expression, which mediates leukocyte adhesion on endothelial cells, otherwise induced by in vivo endotoxin challenge. Six antisense phosphorothioate oligodeoxynucleotides calculated to bind porcine E-selectin mRNA were tested in porcine aortic endothelial cells. One, ISIS9481, exerted significant inhibition of E-selectin expression induced by tumor necrosis factor-α?+?endotoxin [lipopolysaccharide (LPS)]. Pigs were challenged with LPS (10?μg/kg) and treated with ISIS9481 (10?mg/kg) (n?=?6). Two control groups were used, an antisense inactive in porcine aortic endothelial cells (n?=?6) and saline (n?=?5), and were combined as control (C?=?11). Control pigs challenged with LPS expressed E-selectin in heart, lung, kidneys, and liver, whereas antisense-treated pigs expressed little E-selectin in these tissues. Cardiovascular data indicated that antisense treatment attenuated pathophysiological alterations induced by LPS. Specifically, in control pigs, LPS reduced cardiac output 32% from baseline, increased pulmonary (+116%) and systemic vascular resistances (+16%), and generated neutropenia (from 51,000 at basal to 18,000 polymorphonuclear neutrophils (PMN)/μL after LPS). In antisense-treated pigs, cardiac output decreased only 18%, pulmonary vascular resistance remained unchanged, whereas systemic vascular resistance decreased compared with basal values (-37%). PMN counts remained at 45,000-54,000/μL at 3-4 hours after LPS. These data demonstrate that antisense oligodeoxynucleotides, designed and tested in vitro to interact with 1 gene product, can be developed as either therapeutics or experimental tools in vivo.     

Over-expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice

Down syndrome is the most common chromosomal abnormality in humans. Patients with Down syndrome have hematologic disorders, including mild to moderate thrombocytopenia. In case of Down syndrome, thrombocytopenia is not associated with bleeding, and it remains poorly characterized regarding molecular mechanisms. We investigated the effects of overexpression of Dyrk1A, an important factor contributing to some major Down syndrome phenotypes, on platelet number and bleeding in mice. Mice overexpressing Dyrk1A have a decrease in platelet number by 20%. However, bleeding time was found to be reduced by 50%. The thrombocytopenia and the decreased bleeding time observed were not associated to an abnormal platelet receptors expression, to a defect of platelet activation by ADP, thrombin or convulxin, to the presence of activated platelets in the circulation or to an abnormal half-life of the platelets. To propose molecular mechanisms explaining this discrepancy, we performed a network analysis of Dyrk1A interactome and demonstrated that Dyrk1A, fibronectin and fibrinogen interact indirectly through two distinct clusters of proteins. Moreover, in mice overexpressing Dyrk1A, increased plasma fibronectin and fibrinogen levels were found, linked to an increase of the hepatic fibrinogen production. Our results indicate that overexpression of Dyrk1A in mice induces decreased bleeding consistent with increased plasma fibronectin and fibrinogen levels, revealing a new role of Dyrk1A depending on its indirect interaction with these two proteins.     

Survival of Adult Female Bighorn Sheep Following a Pneumonia Epizootic

Beginning in the early 1900s, poly-factorial, poly-microbial pneumonia was identified as a disease affecting bighorn sheep (Ovis canadensis) and it continues to threaten bighorn populations, posing an ongoing management challenge. In May and June 2013, a pneumonia outbreak linked to the pathogen Mycoplasma ovipneumoniae led to an all-age die-off of desert bighorn sheep (O. c. nelsoni) at Old Dad Peak in the Kelso Mountains of the Mojave Desert in California, USA. Subsequently, we observed clinical signs of respiratory disease among bighorn sheep in multiple neighboring ranges. Our objective was to investigate post-outbreak survival of adult female bighorn across 9 populations from 2014 to 2017 in the Mojave Desert and evaluate the relationship between M. ovipneumoniae infection and survival, while testing effects of range factors that could potentially influence differences in adult female survival (i.e., forage quality, winter precipitation, population abundance). We fitted adult females with radio-collars following the outbreak and collected serum and nasal swab samples for competitive enzyme-linked immunosorbent assay (cELISA) and polymerase chain reaction (PCR) testing to determine exposure and infection status at time of capture. We tracked survival of 115 adult females with radio-collars and used the known-fate model in Program MARK to evaluate effects and estimate survival from November 2013 to March 2017. Annual survival was negatively correlated with positive infection status at capture but varied across populations with respect to differences in range conditions. Summer and autumn forage quality, as represented by mean normalized difference vegetation index (NDVI) values for summer and autumn, was positively correlated with overwinter survival, whereas winter precipitation (a proxy for winter severity) was negatively correlated with overwinter survival. Population abundance was negatively correlated with annual survival, suggesting a potential density-dependent effect. Model-averaged annual survival estimates ranged from 0.700 ± 0.07 (SE) to 0.945 ± 0.026 for infected individuals and 0.896 ± 0.03 to 0.983 ± 0.011 for uninfected individuals. We conclude that summer and autumn forage quality, indexed by NDVI, may partially offset the negative effect associated with M. ovipneumoniae infection on host survival. Our survival modeling results suggest that chronic infection may have afflicted adult females that were PCR-positive (i.e., infected with M. ovipneumoniae) at time of capture. We propose programmatic re-testing of infected individuals to assess pathogen persistence at the individual level and evaluate whether selective culling might potentially help to reduce prevalence and transmission within populations. © 2020 The Wildlife Society.     

DROSOPHILA S2 cell culture in a WAVE Bioreactor: potential for scaling up the production of the recombinant rabies virus glycoprotein

Applied Microbiology and Biotechnology - The transmembrane rabies virus glycoprotein (RVGP) is the main antigen of vaccine formulations used around the world to prevent rabies, the most lethal...     

Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1)

Apical membrane antigen 1 (AMA-1) is considered to be a major candidate antigen for a malaria vaccine. Previous immunoepidemiological studies of naturally acquired immunity to Plasmodium vivax AMA-1 (PvAMA-1) have shown a higher prevalence of specific antibodies to domain II (DII) of AMA-1. In the present study, we confirmed that specific antibody responses from naturally infected individuals were highly reactive to both full-length AMA-1 and DII. Also, we demonstrated a strong association between AMA-1 and DII IgG and IgG subclass responses. We analyzed the primary sequence of PvAMA-1 for B cell linear epitopes co-occurring with intrinsically unstructured/disordered regions (IURs). The B cell epitope comprising the amino acid sequence 290–307 of PvAMA-1 (SASDQPTQYEEEMTDYQK), with the highest prediction scores, was identified in domain II and further selected for chemical synthesis and immunological testing. The antigenicity of the synthetic peptide was identified by serological analysis using sera from P. vivax-infected individuals who were knowingly reactive to the PvAMA-1 ectodomain only, domain II only, or reactive to both antigens. Although the synthetic peptide was recognized by all serum samples specific to domain II, serum with reactivity only to the full-length protein presented 58.3% positivity. Moreover, IgG reactivity against PvAMA-1 and domain II after depletion of specific synthetic peptide antibodies was reduced by 18% and 33% (P = 0.0001 for both), respectively. These results suggest that the linear epitope SASDQPTQYEEEMTDYQK is highly antigenic during natural human infections and is an important antigenic region of the domain II of PvAMA-1, suggesting its possible future use in pre-clinical studies.     

Rsf mutants of Escherichia coli HfrC defective in the production of the factor stimulating recombination in conjugation

Summary Male strains of Escherichia coli K12 excrete a protein which stimulates recombination in conjugation. The properties of four Rsf^- mutants unable to produce this recombination-stimulating factor (RSF) have been studied. Two of the mutants have a pleiotropic phenotype which includes hypersensitivity to the lethal effects of ultraviolet (UV) and monofunctional alkylating agents (MAA) and markedly decreased growth rates at elevated temperatures. The latter property is associated with a diminished rate of DNA synthesis. Many more single-strand breaks are detected in the DNA of the pleiotropic mutants after MAA treatment than in the wild type, which are, however, repaired during incubation of the Rsf^- cells after the treatment. No changes in UV-induced DNA breakdown or in host-cell reactivation of bacteriophage T1 have been detected in the mutant. The complete restoration of the wild type characters in Rsf⁺ revertants of these mutants proves that their complex phenotype is due to a single pleiotropic mutation. The integration of the wild type F factor into the chromosome of a derivative of a pleiotropic mutant retaining a portion of a previously integrated sex factor results in the complete restoration of the wild phenotype, which implies that the Rsf^- mutation is located in the episomal DNA. These results show that some products specified by the F factor are necessary for the maintaince of the wild phenotype of Hfr cells. Possible mechanisms of this phenomenon are discussed.     

Unified two-metal mechanism of RNA synthesis and degradation by RNA polymerase

In DNA-dependent RNA polymerases, reactions of RNA synthesis and degradation are performed by the same active center (in contrast to DNA polymerases in which they are separate). We propose a unified catalytic mechanism for multisubunit RNA polymerases based on the analysis of its 3'-5' exonuclease reaction in the context of crystal structure. The active center involves a symmetrical pair of Mg(2+) ions that switch roles in synthesis and degradation. One ion is retained permanently and the other is recruited ad hoc for each act of catalysis. The weakly bound Mg(2+) is stabilized in the active center in different modes depending on the type of reaction: during synthesis by the beta,gamma-phosphates of the incoming substrate; and during hydrolysis by the phosphates of a non-base-paired nucleoside triphosphate. The latter mode defines a transient, non-specific nucleoside triphosphate-binding site adjacent to the active center, which may serve as a gateway for polymerization of substrates.     

Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V

Charcot-Marie-Tooth disease type 2D (CMT2D) and distal spinal muscular atrophy type V (dSMA-V) are axonal peripheral neuropathies inherited in an autosomal dominant fashion. Our previous genetic and physical mapping efforts localized the responsible gene(s) to a well-defined region on human chromosome 7p. Here, we report the identification of four disease-associated missense mutations in the glycyl tRNA synthetase gene in families with CMT2D and dSMA-V. This is the first example of an aminoacyl tRNA synthetase being implicated in a human genetic disease, which makes genes that encode these enzymes relevant candidates for other inherited neuropathies and motor neuron diseases.     

Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1

Lysophosphatidic acid (LPA) is a bioactive molecule involved in inflammation, immunity, wound healing, and neoplasia. Its pleiotropic actions arise presumably by interaction with their cell surface G protein-coupled receptors. Herein, the presence of the specific nuclear lysophosphatidic acid receptor-1 (LPA1R) was revealed in unstimulated porcine cerebral microvascular endothelial cells (pCMVECs), LPA1R stably transfected HTC4 rat hepatoma cells, and rat liver tissue using complementary approaches, including radioligand binding experiments, electron- and cryomicroscopy, cell fractionation, and immunoblotting with three distinct antibodies. Coimmunoprecipitation studies in enriched plasmalemmal fractions of unstimulated pCMVEC showed that LPA1Rs are dually sequestrated in caveolin-1 and clathrin subcompartments, whereas in nuclear fractions LPA1R appeared primarily in caveolae. Immunofluorescent assays using a cell-free isolated nuclear system confirmed LPA1R and caveolin-1 co-localization. In pCMVEC, LPA-stimulated increases in cyclooxygenase-2 and inducible nitric-oxide synthase RNA and protein expression were insensitive to caveolea-disrupting agents but sensitive to LPA-generating phospholipase A2 enzyme and tyrosine kinase inhibitors. Moreover, LPA-induced increases in Ca2+ transients and/or iNOS expression in highly purified rat liver nuclei were prevented by pertussis toxin, phosphoinositide 3-kinase/Akt inhibitor wortmannin and Ca2+ chelator and channel blockers EGTA and SK&F96365, respectively. This study describes for the first time the nucleus as a potential organelle for LPA intracrine signaling in the regulation of pro-inflammatory gene expression.     

Multiple genome rearrangement: a general approach via the evolutionary genome graph

MOTIVATION: In spite of a well-known fact that genome rearrangements are supposed to be viewed in the light of the evolutionary relationships within and between the species involved, no formal underlying framework based on the evolutionary considerations for treating the questions arising in the area has been proposed. If such an underlying framework is provided, all the basic questions in the area can be posed in a biologically more appropriate and useful form: e.g., the similarity between two genomes can then be computed via the nearest ancestor, rather than 'directly', ignoring the evolutionary connections. RESULTS: We outline an evolution-based general framework for answering questions related to the multiple genome rearrangement. In the proposed model, the evolutionary genome graph (EG-graph) encapsulates an evolutionary history of a genome family. For a set of all EG-graphs, we introduce a family of similarity measures, each defined via a fixed set of genome transformations. Given a set of genomes and restricting ourselves to the transpositions, an algorithm for constructing an EG-graph is presented. We also present the experimental results in the form of an EG-graph for a set of concrete genomes (for several species). This EG-graph turns out to be very close to the corresponding known phylogenetic tree.